Compound information
- Natural Products
- ZC1032867
- Molecular Formula
- C17H26N2O4S
- Molecular Weight
- 354.161328312 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-(4-tert-butylphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C17H26N2O4S/c1-5-23-16(20)18-10-12-19(13-11-18)24(21,22)15-8-6-14(7-9-15)17(2,3)4/h6-9H,5,10-13H2,1-4H3
- InChI Key
- IKRJTIJUCQTEAE-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(S(=O)(=O)c2ccc(C(C)(C)C)cc2)CC1
- Source
- ZINC000001073012
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.337 |
LogS | -4.167 | LogD | 3.434 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.053 | Pgp substrate | 0.975 |
HIA | 0.976 | F20 % | 0.906 |
F30 % | 0.851 | Caco-2 | -4.393 |
MDCK | -4.709 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.174 | PPB | 94.666 |
VD | 1.815 | Fu | 0.644 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.098 | CYP1A2 substrate | 0.417 |
CYP2A6 substrate | 0.6 | CYP2B6 substrate | 0.674 |
CYP2C19 inhibitor | 0.892 | CYP2C19 substrate | 0.672 |
CYP2C8 substrate | 0.537 | CYP2C9 inhibitor | 0.636 |
CYP2C9 substrate | 0.995 | CYP2D6 inhibitor | 0.069 |
CYP2D6 substrate | 0.397 | CYP2E1 substrate | 0.491 |
CYP3A4 inhibitor | 0.079 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.244 | CL | 6.735 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.587 | Hepatotoxicity | 0.758 |
Mutagenicity | 0.227 | Rat Oral Acute Toxicity | 0.215 |
FDAMDD | 0.42 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.898 | Eye Corrosion | 0.006 |
Eye Irritation | 0.079 | Respiratory Toxicity | 0.807 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.603 | IGC50 | 3.443 |
LC50FM | 3.043 | LC50DM | 3.897 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.23 | NR-AR-LBD | 0.289 |
NR-AhR | 0.028 | NR-Aromatase | 0.411 |
NR-ER | 0.235 | NR-ER-LBD | 0.403 |
NR-PPAR-gamma | 0.15 | SR-ARE | 0.727 |
SR-ATAD5 | 0.393 | SR-HSE | 0.092 |
SR-MMP | 0.043 | SR-p53 | 0.03 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.